KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly

Author(s):
Akao, H.; Polisecki, E.; Kajinami, K.; Trompet, S.; Robertson, M.; Ford, I.; Jukema, J.W. (0000-0002-3246-8359); Craen, A.J.M. de (0000-0001-9314-123X); Westendorp, R.G.J. (0000-0002-0672-8372); Shepherd, J.; Packard, C.; Buckley, B.M.; Schaefer, E.J.; Prospective Study Pravastatin
Published
2012
Publication type
Article / Letter to editor
KIF6 GeneStatinsLow density lipoprotein cholesterollowering responseHeart disease risk reduction
Date issued
2012-02-28
Language
English
Is part of
Atherosclerosis (2012), Vol. 220, no. 2, p. 456-462
hdl
1887/106042
doi
10.1016/j.atherosclerosis.2011.11.037